Not available
Quote | Signature Bank (NASDAQ:SBNY)
Last: | $70 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $70 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Signature Bank (NASDAQ:SBNY)
2024-06-14 06:14:02 ET New York Community Bancorp ( NYSE: NYCB ) acquired the assets of the failed Signature Bank ( OTC:SBNY ) with an estimated total fair value of $37.8B, the New York-based bank disclosed in a filing on Thursday.... Read the full article on Seeking A...
2024-05-22 17:10:41 ET Gainers: Chicken Soup for the Soul ( CSSEN ) +18% . Signature Bank ( OTC:SBNY ) +7% . PetMed Express ( PETS ) +6% . Prime Medicine ( PRME ) +6% . Sana Biotechnology ( SANA ) +5% . Losers: Cyto...
Message Board Posts | Signature Bank (NASDAQ:SBNY)
Subject | By | Source | When |
---|---|---|---|
Steel Reserve: Going "bank"rupt? This was $125 a few months ago. What's going on with banks? This cu | Steel Reserve | investorshangout | 05/04/2023 2:53:05 AM |
doa even the traders are quiet now | koolmc | investorshub | 05/01/2023 4:14:19 PM |
it's doa | koolmc | investorshub | 04/26/2023 1:51:29 PM |
Classic bull trap past few sessions here, shaked | TimeFades | investorshub | 04/25/2023 3:16:31 PM |
No Idea, just asking but "A bridge bank | PappyVanWinkle | investorshub | 04/24/2023 3:08:28 PM |
News, Short Squeeze, Breakout and More Instantly...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...